Key result
Early thrombolysis in acute ischemic stroke yields good neurological recovery in ~67% of patients.
Why the study?
The number of stroke patients receiving recombinant tissue plasminogen activator (rt-PA) in the developing world, including Nepal, is extremely low and feasibility and efficacy data are lacking.
Observational (n=9)
No
Answers are grounded in this paper and cite their sources.
Suggests early stroke thrombolysis may be feasible in resource-limited settings; leaves open broader safety.
BACKGROUND: Stroke is the major cause of morbidity and mortality worldwide. The number of stroke patients receiving recombinant tissue plasminogen activator (rt-PA), also known as Alteplase, in the developing world is extremely low. We aim to study the feasibility and efficacy of thrombolysis for the 1(st) time in our country. MATERIALS AND METHODS: In this retrospective study (July 2012-August 2015), acute ischemic stroke patients who were thrombolyzed within 3 h of stroke onset were included. Their demographic profiles, clinical profiles, risk factors, type of thrombolytic used, and outcomes were systematically recorded and analyzed. RESULTS: A total of 9 patients were thrombolyzed. The mean time from the onset of stroke symptoms to first dose of rt-PA (onset to treatment) was 1.2 h. Six patients had good neurological outcome as measured by modified Rankin Scale (mRS). The median mRS at discharge was 3. Thrombolysis-related post treatment complication was noted in 44.4%, of which nonfatal intracranial bleed occurred only in 2 patients (22.2%). None of the patients receiving intravenous tenecteplase had thrombolysis-related complications, and none of the patients had fatal intracranial bleed. CONCLUSION: This study clearly demonstrates the beginning of a feasible and effective thrombolysis in the treatment of acute ischemic stroke in Nepal.
No takes yet. Share an insight, caveat, or question.
Thapa et al. (2015) conducted an observational in Acute ischemic stroke (n=9). Thrombolysis (rt-PA or Tenecteplase) was evaluated on Good neurological outcome (as measured by mRS or NIHSS). Thrombolysis within 3 hours of onset was feasible in 9 acute ischemic stroke patients in Nepal, resulting in a good neurological outcome for 66.6% of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: